Literature DB >> 8035520

Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli.

L J Henry1, D Xia, M E Wilke, J Deisenhofer, R D Gerard.   

Abstract

The adenovirus fiber protein is used for attachment of the virus to a specific receptor on the cell surface. Structurally, the protein consists of a long, thin shaft that protrudes from the vertex of the virus capsid and terminates in a globular domain termed the knob. To verify that the knob is the domain which interacts with the cellular receptor, we have cloned and expressed the knob from adenovirus type 5 together with a single repeat of the shaft in Escherichia coli. The protein was purified by conventional chromatography and functionally characterized for its interaction with the adenovirus receptor. The recombinant knob domain bound about 4,700 sites per HeLa cell with an affinity of 3 x 10(9) M-1 and blocked adenovirus infection of human cells. Antibodies raised against the knob also blocked virus infection. By gel filtration and X-ray diffraction analysis of protein crystals, the knob was shown to consist of a homotrimer of 21-kDa subunits. The results confirm that the trimeric knob is the ligand for attachment to the adenovirus receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035520      PMCID: PMC236468     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Sensitization and neutralization of adenovirus by specific sera against capsid subunits.

Authors:  G Wadell
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

2.  Determination of protein molecular weight, hydration, and packing from crystal density.

Authors:  B W Matthews
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein.

Authors:  C Signäs; G Akusjärvi; U Pettersson
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Interactions of KB-cell glycoproteins with an adenovirus capsid protein.

Authors:  A Meager; T D Butters; V Mautner; R C Hughes
Journal:  Eur J Biochem       Date:  1976-01-15

5.  Molecular composition of the adenovirus type 2 virion.

Authors:  J van Oostrum; R M Burnett
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

6.  Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of the HeLa cell plasma membrane.

Authors:  U Svensson; R Persson; E Everitt
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  Virus-receptor interaction in the adenovirus system: characterization of the positive cooperative binding of virions on HeLa cells.

Authors:  R Persson; C Wohlfart; U Svensson; E Everitt
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

8.  The sequence of adenovirus fiber: similarities and differences between serotypes 2 and 5.

Authors:  J Chroboczek; B Jacrot
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

9.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  Virus receptor interaction in the adenovirus system. II. Capping and cooperative binding of virions on HeLa cells.

Authors:  R Persson; U Svensson; E Everitt
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  79 in total

1.  Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines.

Authors:  Toshiro Seki; Igor Dmitriev; Elena Kashentseva; Koichi Takayama; Marianne Rots; Kaori Suzuki; David T Curiel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.

Authors:  M B Parrott; M A Barry
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

3.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Adenovirus type 11 uses CD46 as a cellular receptor.

Authors:  Anna Segerman; John P Atkinson; Marko Marttila; Veronica Dennerquist; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Authors:  Zeng B Zhu; Angel A Rivera; Sharmila K Makhija; Baogen Lu; Minghui Wang; Miiru Izumi; Robert J Cerfolio; Mariam A Stoff-Khalili; Fen Zhou; Koichi Takayama; Gene P Siegal; David T Curiel
Journal:  Lung Cancer       Date:  2006-11-17       Impact factor: 5.705

Review 7.  Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.

Authors:  J Michael Mathis; Phoebe L Stewart; Zheng B Zhu; David T Curiel
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

8.  The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p.

Authors:  Dan J Gustafsson; Anna Segerman; Kristina Lindman; Ya-Fang Mei; Göran Wadell
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.

Authors:  Natalya Belousova; Galina Mikheeva; Juri Gelovani; Victor Krasnykh
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Ex vivo transfer of the Hoxc-8-interacting domain of Smad1 by a tropism-modified adenoviral vector results in efficient bone formation in a rabbit model of spinal fusion.

Authors:  Joanne T Douglas; Angel A Rivera; Gray R Lyons; Patricia F Lott; Dezhi Wang; Majd Zayzafoon; Gene P Siegal; Xu Cao; Steven M Theiss
Journal:  J Spinal Disord Tech       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.